Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 16Observational 2

Sponsor

Cancer Type

Endocrine 2Head & Neck 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Carcinoma, Neuroendocrine 1Adenocarcinoma, Follicular 1

Interventions

Blood Specimen Collection 137Surveys and Questionnaires 131Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 35Drug Therapy 31Surgical Procedures, Operative 31Biopsy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Watchful Waiting 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 17Standard of Care 17Therapeutics 17Immunotherapy 16palbociclib 14trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13Hematologic Tests 12Radiosurgery 12Focus Groups 11Genetic Testing 11darolutamide 11enzalutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × gallium Ga 68 dotatate × 1 year × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT04069299 2026-03-31

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

H. Lee Moffitt Cancer Center and Research Institute

Completed
30 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡